CA Stock MarketDetailed Quotes

MDNA Medicenna Therapeutics Corp

Watchlist
  • 1.650
  • -0.180-9.84%
15min DelayMarket Closed Jun 20 16:00 ET
123.39MMarket Cap-7173P/E (TTM)

Medicenna Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
63.60%33.6M
54.55%36.15M
49.91%40.01M
-46.24%19.3M
-49.15%20.54M
-49.15%20.54M
-Cash and cash equivalents
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
63.60%33.6M
54.55%36.15M
139.73%40.01M
-25.49%19.3M
-32.40%20.54M
-32.40%20.54M
Total current assets
-39.10%23.21M
-34.86%27.68M
56.84%31.49M
55.55%36.39M
55.55%36.39M
46.39%38.11M
41.61%42.5M
-46.10%20.08M
-44.50%23.39M
-44.50%23.39M
Non current assets
-Goodwill
-6.45%58K
-6.35%59K
-7.69%60K
-6.15%61K
-6.15%61K
-8.82%62K
-8.70%63K
-7.14%65K
-8.45%65K
-8.45%65K
Regulatory assets
125.14%403K
105.37%306K
788.30%835K
-34.63%855K
-34.63%855K
-70.36%179K
-65.35%149K
-89.65%94K
219.02%1.31M
219.02%1.31M
Total assets
----
----
----
-34.63%855K
-34.63%855K
----
----
----
219.02%1.31M
219.02%1.31M
Liabilities
Current liabilities
-accounts payable
----
----
----
-3.29%1.62M
-3.29%1.62M
----
----
----
-25.52%1.67M
-25.52%1.67M
-Total tax payable
-68.72%613K
-89.29%611K
--1.41M
--3.16M
--3.16M
--1.96M
--5.71M
--0
--0
--0
Current accrued expenses
----
----
----
130.03%2.18M
130.03%2.18M
----
----
----
-48.09%949K
-48.09%949K
Current liabilities
34.69%4.03M
25.81%3.7M
50.58%3.23M
44.98%3.8M
44.98%3.8M
27.14%2.99M
-45.92%2.94M
-56.70%2.15M
-36.18%2.62M
-36.18%2.62M
Non current liabilities
Derivative product liabilities
-68.72%613K
-92.06%453K
--1.41M
--3.16M
--3.16M
--1.96M
--5.71M
----
--0
--0
Total non current liabilities
-6.26%4.64M
-50.19%4.31M
116.39%4.65M
165.55%6.96M
165.55%6.96M
110.51%4.95M
59.16%8.64M
-56.70%2.15M
-36.18%2.62M
-36.18%2.62M
Shareholders'equity
Share capital
0.00%100.92M
-0.05%100.92M
19.24%100.92M
20.62%100.92M
20.62%100.92M
20.76%100.92M
26.10%100.98M
5.91%84.64M
5.13%83.67M
5.13%83.67M
-common stock
0.00%100.92M
-0.05%100.92M
19.24%100.92M
20.62%100.92M
20.62%100.92M
20.76%100.92M
26.10%100.98M
5.91%84.64M
5.13%83.67M
5.13%83.67M
Additional paid-in capital
9.86%10.21M
14.68%10.05M
17.39%9.78M
19.68%9.49M
19.68%9.49M
20.74%9.29M
20.26%8.76M
19.45%8.33M
18.65%7.93M
18.65%7.93M
Gains losses not affecting retained earnings
-70.15%40K
-81.25%30K
-65.74%37K
-66.67%57K
-66.67%57K
-37.96%134K
-27.27%160K
-53.04%108K
-26.92%171K
-26.92%171K
Total equity
-39.05%23.27M
-34.81%27.74M
56.63%31.55M
55.38%36.45M
55.38%36.45M
46.22%38.17M
41.43%42.56M
-46.06%20.14M
-44.49%23.46M
-44.49%23.46M
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M63.60%33.6M54.55%36.15M49.91%40.01M-46.24%19.3M-49.15%20.54M-49.15%20.54M
-Cash and cash equivalents -39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M63.60%33.6M54.55%36.15M139.73%40.01M-25.49%19.3M-32.40%20.54M-32.40%20.54M
Total current assets -39.10%23.21M-34.86%27.68M56.84%31.49M55.55%36.39M55.55%36.39M46.39%38.11M41.61%42.5M-46.10%20.08M-44.50%23.39M-44.50%23.39M
Non current assets
-Goodwill -6.45%58K-6.35%59K-7.69%60K-6.15%61K-6.15%61K-8.82%62K-8.70%63K-7.14%65K-8.45%65K-8.45%65K
Regulatory assets 125.14%403K105.37%306K788.30%835K-34.63%855K-34.63%855K-70.36%179K-65.35%149K-89.65%94K219.02%1.31M219.02%1.31M
Total assets -------------34.63%855K-34.63%855K------------219.02%1.31M219.02%1.31M
Liabilities
Current liabilities
-accounts payable -------------3.29%1.62M-3.29%1.62M-------------25.52%1.67M-25.52%1.67M
-Total tax payable -68.72%613K-89.29%611K--1.41M--3.16M--3.16M--1.96M--5.71M--0--0--0
Current accrued expenses ------------130.03%2.18M130.03%2.18M-------------48.09%949K-48.09%949K
Current liabilities 34.69%4.03M25.81%3.7M50.58%3.23M44.98%3.8M44.98%3.8M27.14%2.99M-45.92%2.94M-56.70%2.15M-36.18%2.62M-36.18%2.62M
Non current liabilities
Derivative product liabilities -68.72%613K-92.06%453K--1.41M--3.16M--3.16M--1.96M--5.71M------0--0
Total non current liabilities -6.26%4.64M-50.19%4.31M116.39%4.65M165.55%6.96M165.55%6.96M110.51%4.95M59.16%8.64M-56.70%2.15M-36.18%2.62M-36.18%2.62M
Shareholders'equity
Share capital 0.00%100.92M-0.05%100.92M19.24%100.92M20.62%100.92M20.62%100.92M20.76%100.92M26.10%100.98M5.91%84.64M5.13%83.67M5.13%83.67M
-common stock 0.00%100.92M-0.05%100.92M19.24%100.92M20.62%100.92M20.62%100.92M20.76%100.92M26.10%100.98M5.91%84.64M5.13%83.67M5.13%83.67M
Additional paid-in capital 9.86%10.21M14.68%10.05M17.39%9.78M19.68%9.49M19.68%9.49M20.74%9.29M20.26%8.76M19.45%8.33M18.65%7.93M18.65%7.93M
Gains losses not affecting retained earnings -70.15%40K-81.25%30K-65.74%37K-66.67%57K-66.67%57K-37.96%134K-27.27%160K-53.04%108K-26.92%171K-26.92%171K
Total equity -39.05%23.27M-34.81%27.74M56.63%31.55M55.38%36.45M55.38%36.45M46.22%38.17M41.43%42.56M-46.06%20.14M-44.49%23.46M-44.49%23.46M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg